LINC00337 was upregulated in pancreatic ductal adenocarcinoma (PDAC) and facilitated PDAC cell proliferation, along with cell cycle transition, by acting as an E2F1 co-activator through its binding to E2F1 [68]. Here, E2F1 is linked to pancreatic ductal adenocarcinoma.